Stocks
Exelixis (EXEL) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 2 626% | 1 805% | 1 080% | 644.1% | 640.7% | 782.2% | |||
| Changes by years, y/y, % | 0pp | -820pp | -725pp | -436pp | -3pp | +3.2% | |||
Exelixis. R&D/CAPEX, %
Exelixis. R&D/CAPEX, changes, pp
Exelixis (EXEL) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 482.7% | 3 127% | 354.3% | 1 863% | 1 252% | 782.2% | ||
| Changes by years, y/y, % | -2 310pp | +1 510pp | -2 118pp | +1 563pp | +769pp | |||
| Changes by quarters, q/q, % | +183pp | +2 644pp | -2 773pp | +1 508pp | -611pp | |||
